2022³â ´ëÇѹÙÀÌ·¯½ºÇÐȸ Á¤±âÇмú´ëȸ : 2022-08-27±³À°ÀÏÀÚ : 2022-08-27
±³À°Àå¼Ò : À»ÁöÀη°³¹ß¿ø
±³À°ÁÖÁ¦ :
2022³â ´ëÇѹÙÀÌ·¯½ºÇÐȸ Á¤±âÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѹÙÀÌ·¯½ºÇÐȸ
´ã´çÀÚ : ÃÖ¼¼ÀÎ
¿¬¶ôó : 070-8886-3062
À̸ÞÀÏ :
virology@ksov.org ±³À°Á¾·ù : ÀÇ»çÇйýÀÇÇп¹¹æÀÇÇÐÇغÎÇлý¸®ÇлýÈÇкÐÀÚ»ý¹°Çй̻ý¹°Çбâ»ýÃæÇоฮÇÐ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
°¿øµµ±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í ÆòÀÇ¿ø: ÀÏ¹Ý 20¸¸¿ø, Çлý 8¸¸¿ø Á¤È¸¿ø: ÀÏ¹Ý 15¸¸¿ø, Çлý 8¸¸¿ø ºñȸ¿ø: ÀÏ¹Ý 15¸¸¿ø, Çлý 8¸¸¿ø ÇöÀåµî·Ï: ÀÏ¹Ý 20¸¸¿ø, Çлý 10¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 09:30~09:50 Modeling how peginterferon alfa improves clearance rates of cccDNA in hepatitis B virus infected patients ±è±¤¼ö(ºÎ°æ´ëÇб³ °úÇнýºÅ۽ùķ¹À̼ÇÇаú)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 09:50~10:10 Antiviral activity of activated cdc42-associated kinase 1 against hepatitis B virus ¹Ú¿ë±¤(±¹¸³º¸°Ç¿ø ¸¸¼º¹ÙÀÌ·¯½º¿¬±¸°ú)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 10:10~10:30 Role of p62/SQSTM1 in ZIKV Pathogenesis ±è¼ºÁØ(Çѱ¹ÈÇבּ¸¿ø)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 10:30~10:45 SARS-CoV-2 productively infects human hepatocytes and induces cell death °íõ±Ô(Çѱ¹ÈÇבּ¸¿ø)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 10:45~11:00 Host sensing of RNA viruses and the viral evasion strategies: From fundamental mechanism study to the development of the screening tool À¯Áö½Â(±âÃÊ°úÇבּ¸¿ø Çѱ¹¹ÙÀÌ·¯½º±âÃÊ¿¬±¸¼Ò)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 11:00~11:15 CaMKII Inhibits HBV Replication via AMPK/AKT/mTOR Signaling pathways ±èÁÖ¹Ì(¾ÆÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 11:15~11:30 The regulatory T cell population is not normalized following successfultreatment of chronic hepatitis C with direct-acting antivirals ±è¼Ò¿µ(KAIST)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 13:05~13:30 Viral G-quadruplex as a promising target to control SARS-CoV-2 infection ¼Û¹®Á¤(°í·Á´ëÇб³ »ý¸í°úÇдëÇÐ)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 13:30~13:55 Preparedness against Viral Disease X with active surveillance from wild life animals and nanobiotechnology for diagnosis, antiviral, and vaccine ¼Û´ë¼·(¼¿ï´ëÇб³ ¼öÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 13:55~14:20 Influenza and SARS-CoV-2 co-infection alters viral tropism in Syrian hamsters À±¼±¿ì(Çѱ¹»ý¸í°øÇבּ¸¿ø)
Åä·Ð 08-27 ´ë°ÀÇ½Ç 14:20~14:40 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 14:40~14:52 SARS-CoV-2 omicron mainly utilizes cathepsin for infectivity and fusogenicity ÀåÀǼø(°í·Á´ëÇб³ »ý¸íÁ¤º¸Çаú)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 14:52~15:04 Definition and correlation analysis of bimodal distribution of sequencing data of transcriptome and chromatin accessibility ±è±¤ÈÆ(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 15:04~15:16 Single Cell Transcriptomic Analysis of Human Lung Organoids to model SARS-CoV-2 Infection À̼¼À±(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 15:16~15:28 Aging dependent Immunopathology of the COVID-19 : The potent guardians, Innate lymphoid cells Àӹοµ(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 15:28~15:40 Development of humanized ACE2-expressing mouse model for COVID-19 ¹Ú¿îÀÌ(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 08-27 ´ë°ÀÇ½Ç 15:40~15:52 Mutation patterns of SARS-CoV-2 through serial passage in human cell lines ³ëÁö¿µ(ÃæºÏ´ëÇб³ »ý¸í½Ã½ºÅÛÇаú)
Åä·Ð 08-27 ´ë°ÀÇ½Ç 15:52~16:10 ÁúÀÇÀÀ´ä ()